Treatment of cerebral vasospasm secondary to subarachnoid hemorrhage utilizing the Comaneci device
Autor: | Hamza Shaikh, Brian T Jankowitz, Clint A. Badger |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Subarachnoid hemorrhage Computed Tomography Angiography medicine.medical_treatment 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Cerebral vasospasm Angioplasty medicine Humans Vasospasm Intracranial cardiovascular diseases Stroke business.industry Stent Vasospasm Bleed Subarachnoid Hemorrhage medicine.disease Aneurysm Embolization Therapeutic Magnetic Resonance Imaging nervous system diseases Cerebral Angiography Hemiparesis Anesthesia cardiovascular system Female medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Interv Neuroradiol |
Popis: | Delayed cerebral ischemia due to vasospasm following subarachnoid hemorrhage continues to have high morbidity and mortality despite current treatments. This report highlights the use of the Comaneci (Rapid Medical, Yokneam, Israel), a device FDA approved for temporary coil embolization assistance, for the treatment of symptomatic vasospasm. Ten days post subarachnoid hemorrhage, a patient developed acute left-sided hemiparesis with angiographic vasospasm. Through a Headway 17 microcatheter, a Comaneci 17 was deployed in the right ICA terminus, M1, M2, A1, and, A2 segments resulting in improvement of angiographic vasospasm and the patient’s left-sided hemiparesis. On the following day, a repeat angiogram demonstrated no recurrence of vasospasm. The patient had complete return on neurologic function by post bleed day 18 continuing to her four-week follow-up appointment. This case demonstrates the feasibility of the Comaneci device as an effective tool in the treatment of vasospasm following subarachnoid hemorrhage. |
Databáze: | OpenAIRE |
Externí odkaz: |